As an experienced corporate transactional lawyer and a partner in our Corporate Group in The Hague, I work across the private and public markets, with a specific focus on life sciences.

I advise on cross-border mergers and acquisitions, private equity and venture capital, public-to-private transactions and other corporate transactions, as well as securities law and financial supervision, corporate governance and general corporate matters.

In addition, I have significant experience in advising issuers and investment banks on equity capital markets transactions, such as securities offerings in the public and private markets, IPOs, private placements, rights issues and block trades.

Project management is crucial to our client service and over the years I have led various multidisciplinary teams on large and complex transactions, both domestically and cross-border.

I have a particular focus on and experience in the life sciences sector. Bird & Bird is one of the world's leading firms in life sciences and healthcare and that expertise together with our one firm approach internationally means we can offer great service and consistency on cross-border deals. We use that in-depth knowledge to help our clients understand risk profiles and guide them through a transaction.

I have extensive experience in providing strategic and boardroom advice. Over the years, I have been Corporate Secretary at two listed companies, including a listed life sciences company. Consequently, I know the 'inner workings' of listed companies, which I consider a great benefit when advising my clients.

I frequently teach courses and give training sessions. I am a lecturer in corporate law at the Law Firm School, the educational institute of the leading law firms in the Netherlands.

I am currently completing a Masters in Finance from Amsterdam Business School. The financial acumen that I acquired as a consequence greatly contributes to my ability to effectively assist my clients on their transactions, because being a good transactional lawyer not only requires excellent legal knowledge but also a high degree of financial literacy.

  • Advising on the formation of a Sino-Dutch joint venture creating a global leader in sustainable antibiotics
  • Advising the lead investor and life sciences-focused investment firm on a USD 30m Series B financing round of a Dutch biotech company
  • Advising on the initial public offerings and Euronext Amsterdam listings of several companies
  • Advising on the public-to-private of an Euronext Amsterdam listed life sciences company
  • Advising on the EUR510 million disposal of a leading Benelux DYI business
Education
  • University of Amsterdam Business School, Master in Finance
  • Amsterdam Institute of Fnance, Corporate Finance for Lawyers
  • Grotius Academy, Nijmegen Law School, Securities Laws
  • Leiden University, Master of Laws, Law
  • Université de Bourgogne, Droit Civil
Admissions
  • Dutch Bar in 1997